Quadrant Capital Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,710
| Closed | -$167K | – | 2232 |
|
|
2025
Q1 | $167K | Buy |
6,710
+6,155
| +1,109% | +$153K | 0.01% | 1377 |
|
|
2024
Q4 | $10.5K | Buy |
555
+86
| +18% | +$1.62K | ﹤0.01% | 2113 |
|
|
2024
Q3 | $7.06K | Sell |
469
-18
| -4% | -$271 | ﹤0.01% | 2237 |
|
|
2024
Q2 | $13.9K | Sell |
487
-839
| -63% | -$24K | ﹤0.01% | 2001 |
|
|
2024
Q1 | $38.7K | Sell |
1,326
-998
| -43% | -$29.2K | ﹤0.01% | 1529 |
|
|
2023
Q4 | $78.4K | Buy |
2,324
+885
| +62% | +$29.9K | 0.01% | 1136 |
|
|
2023
Q3 | $44.1K | Sell |
1,439
-55
| -4% | -$1.69K | ﹤0.01% | 1334 |
|
|
2023
Q2 | $59.9K | Sell |
1,494
-1,402
| -48% | -$56.2K | 0.01% | 1162 |
|
|
2023
Q1 | $118K | Buy |
2,896
+1,947
| +205% | +$79.5K | 0.01% | 743 |
|
|
2022
Q4 | $36.6K | Buy |
949
+74
| +8% | +$2.86K | ﹤0.01% | 1361 |
|
|
2022
Q3 | $47K | Buy |
875
+693
| +381% | +$37.2K | 0.01% | 1075 |
|
|
2022
Q2 | $11K | Buy |
182
+48
| +36% | +$2.9K | ﹤0.01% | 1620 |
|
|
2022
Q1 | $10K | Hold |
134
| – | – | ﹤0.01% | 1655 |
|
|
2021
Q4 | $8K | Sell |
134
-6
| -4% | -$358 | ﹤0.01% | 1729 |
|
|
2021
Q3 | $8K | Buy |
140
+6
| +4% | +$343 | ﹤0.01% | 1716 |
|
|
2021
Q2 | $8K | Hold |
134
| – | – | ﹤0.01% | 1680 |
|
|
2021
Q1 | $9K | Hold |
134
| – | – | ﹤0.01% | 1557 |
|
|
2020
Q4 | $8K | Hold |
134
| – | – | ﹤0.01% | 1507 |
|
|
2020
Q3 | $8K | Hold |
134
| – | – | ﹤0.01% | 1333 |
|
|
2020
Q2 | $7K | Buy |
134
+86
| +179% | +$4.49K | ﹤0.01% | 1510 |
|
|
2020
Q1 | $2K | Buy |
+48
| New | +$2K | ﹤0.01% | 1885 |
|
|
2019
Q3 | – | Sell |
-712
| Closed | -$30K | – | 2364 |
|
|
2019
Q2 | $30K | Buy |
+712
| New | +$30K | ﹤0.01% | 1453 |
|
|
2018
Q2 | – | Sell |
-111
| Closed | -$3K | – | 2190 |
|
|
2018
Q1 | $3K | Buy |
+111
| New | +$3K | ﹤0.01% | 1725 |
|
|
2016
Q2 | – | Sell |
-96
| Closed | -$5K | – | 2049 |
|
|
2016
Q1 | $5K | Buy |
96
+16
| +20% | +$833 | ﹤0.01% | 1170 |
|
|
2015
Q4 | $6K | Buy |
+80
| New | +$6K | ﹤0.01% | 998 |
|